Evidence map›Paper›PMID 41645409›Full record

ArticleJournal of cutaneous pathology2026

Harnessing Digital Pathology Tools to Distinguish Hand Eczema From Palmar Psoriasis: A Quantitative Approach.

Melissa Sari, Stefan Schliep, Anne Petzold, Franklin Kiesewetter, Michael Erdmann, Michael Sticherling, Carola Berking, Markus V Heppt, Elias A T Koch

Abstract read
In one paragraph

Article in Journal of cutaneous pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Melissa SariDepartment of Dermatology, Deutsches Zentrum Immuntherapie (DZI), Comprehensive Cancer Center (CCC) Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Stefan SchliepDepartment of Dermatology, Deutsches Zentrum Immuntherapie (DZI), Comprehensive Cancer Center (CCC) Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Anne PetzoldDepartment of Dermatology, Deutsches Zentrum Immuntherapie (DZI), Comprehensive Cancer Center (CCC) Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Franklin KiesewetterMVZ Pathology, Bamberg, Germany.
Michael ErdmannDepartment of Dermatology, Deutsches Zentrum Immuntherapie (DZI), Comprehensive Cancer Center (CCC) Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Michael SticherlingDepartment of Dermatology, Deutsches Zentrum Immuntherapie (DZI), Comprehensive Cancer Center (CCC) Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.ORCID https://orcid.org/0000-0001-9396-3938
Carola BerkingDepartment of Dermatology, Deutsches Zentrum Immuntherapie (DZI), Comprehensive Cancer Center (CCC) Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.ORCID https://orcid.org/0000-0003-0229-8931
Markus V HepptDepartment of Dermatology, Deutsches Zentrum Immuntherapie (DZI), Comprehensive Cancer Center (CCC) Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.ORCID https://orcid.org/0000-0003-4603-1825
Elias A T KochDepartment of Dermatology, Deutsches Zentrum Immuntherapie (DZI), Comprehensive Cancer Center (CCC) Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.ORCID https://orcid.org/0000-0003-2005-7533

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDistinguishing hand eczema from palmar psoriasis is a common diagnostic challenge due to overlapping clinical and histopathological features.

objectiveThis study aimed to validate morphological and immunohistochemical criteria for differentiating these two conditions using the digital pathology tools QuPath and ImageJ.

methodsOne hundred forty-two histological samples with confirmed clinical diagnoses were stained with hematoxylin and eosin and subjected to immunohistochemical staining for CD3, CD15, CD20, CD123, S100, and PHH3. The samples were digitized for analysis. QuPath was used to automate annotation, segment epidermal layers, and measure rete ridge elongation, width, and suprapapillary epidermal thickness. Immunohistochemical markers were also analyzed using QuPath. ImageJ was employed to quantify spongiosis using color thresholding techniques.

resultsSuprapapillary epidermal thickness was significantly lower in psoriasis compared to eczema (p < 0.001; AUC = 0.72). Rete ridge elongation (p = 0.002; AUC = 0.704) and width (p < 0.001; AUC = 0.698) also showed significant differences. Furthermore, hypogranulosis was more pronounced in psoriasis (p = 0.012; AUC = 0.602), while S100-positive cells in the epidermis were more commonly observed in eczema (p = 0.013; AUC = 0.583).

conclusionQuantitative assessment of suprapapillary epidermal thickness and rete ridge morphology offers a reliable and objective method for differentiating palmar psoriasis from hand eczema, enhancing diagnostic accuracy.

Indexed as

EczemaHand DermatosesPsoriasisAdultAgedDiagnosis, DifferentialEpidermisFemaleHandHumansImmunohistochemistryMaleMiddle Ageddermatopathologyhand dermatitishand eczemaimmunohistochemistrypalmar psoriasisQuPath

Identifiers

PMID41645409
PMCPMC13040410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.